Markus E. Diefenbacher

2.6k total citations
42 papers, 1.9k citations indexed

About

Markus E. Diefenbacher is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Markus E. Diefenbacher has authored 42 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 20 papers in Oncology and 6 papers in Genetics. Recurrent topics in Markus E. Diefenbacher's work include Ubiquitin and proteasome pathways (16 papers), Cancer-related Molecular Pathways (10 papers) and RNA modifications and cancer (7 papers). Markus E. Diefenbacher is often cited by papers focused on Ubiquitin and proteasome pathways (16 papers), Cancer-related Molecular Pathways (10 papers) and RNA modifications and cancer (7 papers). Markus E. Diefenbacher collaborates with scholars based in Germany, United Kingdom and Spain. Markus E. Diefenbacher's co-authors include Axel Behrens, Julian Downward, Gordon Stamp, Madhu Kumar, Emma Nye, Atanu Chakraborty, Martin Eilers, Olivier Kassel, Nikita Popov and Rocı́o Sancho and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Markus E. Diefenbacher

41 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus E. Diefenbacher Germany 23 1.4k 567 296 212 186 42 1.9k
Chiharu Uchida Japan 26 2.0k 1.4× 679 1.2× 320 1.1× 220 1.0× 181 1.0× 65 2.5k
Sohee Jun United States 21 1.4k 1.0× 412 0.7× 322 1.1× 168 0.8× 107 0.6× 28 2.0k
Hui Dai United States 23 1.3k 0.9× 677 1.2× 280 0.9× 155 0.7× 142 0.8× 58 1.6k
Yasuhiko Takahashi Japan 13 1.7k 1.2× 853 1.5× 259 0.9× 217 1.0× 114 0.6× 32 2.2k
Matthieu Lacroix France 18 1.1k 0.8× 516 0.9× 302 1.0× 245 1.2× 261 1.4× 28 2.0k
Kevin Myant United Kingdom 20 1.4k 1.0× 777 1.4× 278 0.9× 226 1.1× 219 1.2× 28 2.0k
Larisa Litovchick United States 24 1.4k 1.0× 669 1.2× 245 0.8× 293 1.4× 119 0.6× 54 1.8k
Bastiaan Evers Netherlands 21 1.8k 1.2× 995 1.8× 369 1.2× 155 0.7× 246 1.3× 39 2.4k
Yoko Itahana United States 24 2.0k 1.4× 896 1.6× 516 1.7× 191 0.9× 160 0.9× 40 2.6k
Yuval Tabach Israel 20 1.6k 1.1× 479 0.8× 460 1.6× 120 0.6× 124 0.7× 49 2.1k

Countries citing papers authored by Markus E. Diefenbacher

Since Specialization
Citations

This map shows the geographic impact of Markus E. Diefenbacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus E. Diefenbacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus E. Diefenbacher more than expected).

Fields of papers citing papers by Markus E. Diefenbacher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus E. Diefenbacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus E. Diefenbacher. The network helps show where Markus E. Diefenbacher may publish in the future.

Co-authorship network of co-authors of Markus E. Diefenbacher

This figure shows the co-authorship network connecting the top 25 collaborators of Markus E. Diefenbacher. A scholar is included among the top collaborators of Markus E. Diefenbacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus E. Diefenbacher. Markus E. Diefenbacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fernández, Silvia, Martín Garrido‐Rodríguez, Susana de la Luna, et al.. (2025). A novel feedback loop between DYRK2 and USP28 regulates cancer homeostasis and DNA damage signaling. Cell Death and Differentiation. 33(1). 77–91. 2 indexed citations
2.
Liu, Yue, Þorkell Andrésson, William C. Reinhold, et al.. (2024). Metabolism‐focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer. Molecular Carcinogenesis. 63(6). 1024–1037. 1 indexed citations
3.
Hartmann, Oliver, Cristian Prieto‐Garcia, Kamal M. Al-Shami, et al.. (2023). USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancer. Cell Death and Differentiation. 30(7). 1710–1725. 21 indexed citations
4.
Strubel, Alexander, Oliver Hartmann, A. Chaikuad, et al.. (2023). DARPins detect the formation of hetero-tetramers of p63 and p73 in epithelial tissues and in squamous cell carcinoma. Cell Death and Disease. 14(10). 674–674. 7 indexed citations
5.
Fischer, Thomas, Oliver Hartmann, Cristian Prieto‐Garcia, et al.. (2022). PTEN mutant non-small cell lung cancer require ATM to suppress pro-apoptotic signalling and evade radiotherapy. Cell & Bioscience. 12(1). 50–50. 16 indexed citations
6.
Novak, Rostislav, Michael Timaner, Oliver Hartmann, et al.. (2022). RNF4~RGMb~BMP6 axis required for osteogenic differentiation and cancer cell survival. Cell Death and Disease. 13(9). 820–820. 7 indexed citations
7.
Roth, Sabine, Ursula G. Sauer, Katja Maurus, et al.. (2022). Autophagy Blockage Reduces the Incidence of Pancreatic Ductal Adenocarcinoma in the Context of Mutant Trp53. Frontiers in Cell and Developmental Biology. 10. 785252–785252. 2 indexed citations
8.
Prieto‐Garcia, Cristian, Oliver Hartmann, Thomas Fischer, et al.. (2021). Inhibition of USP28 overcomes Cisplatin-resistance of squamous tumors by suppression of the Fanconi anemia pathway. Cell Death and Differentiation. 29(3). 568–584. 24 indexed citations
9.
Ruiz, E. Josue, Linxiang Lan, Markus E. Diefenbacher, et al.. (2021). JunD, not c-Jun, is the AP-1 transcription factor required for Ras-induced lung cancer. JCI Insight. 6(13). 29 indexed citations
10.
Bauer, Benedikt, et al.. (2021). Exploration of zebrafish larvae as an alternative whole-animal model for nephrotoxicity testing. Toxicology Letters. 344. 69–81. 13 indexed citations
11.
Prieto‐Garcia, Cristian, Oliver Hartmann, Fabian Braun, et al.. (2020). Maintaining protein stability of ∆Np63 via USP 28 is required by squamous cancer cells. EMBO Molecular Medicine. 12(4). e11101–e11101. 43 indexed citations
12.
Schmidt, Stefanie, Guntram Schwarz, Markus E. Diefenbacher, et al.. (2020). CIP2A regulates MYC translation (via its 5′UTR) in colorectal cancer. International Journal of Colorectal Disease. 36(5). 911–918. 9 indexed citations
13.
Ruiz, E. Josue, Markus E. Diefenbacher, Jessica K. Nelson, et al.. (2019). LUBAC determines chemotherapy resistance in squamous cell lung cancer. The Journal of Experimental Medicine. 216(2). 450–465. 60 indexed citations
14.
Rötzer, Vera, et al.. (2018). Dsg2 via Src-mediated transactivation shapes EGFR signaling towards cell adhesion. Cellular and Molecular Life Sciences. 75(22). 4251–4268. 27 indexed citations
15.
Diefenbacher, Markus E., Atanu Chakraborty, Sophia M. Blake, et al.. (2015). Usp28 Counteracts Fbw7 in Intestinal Homeostasis and Cancer. Cancer Research. 75(7). 1181–1186. 60 indexed citations
16.
Cremona, Catherine A., Rocı́o Sancho, Markus E. Diefenbacher, & Axel Behrens. (2015). Fbw7 and its counteracting forces in stem cells and cancer: Oncoproteins in the balance. Seminars in Cancer Biology. 36. 52–61. 30 indexed citations
17.
Diefenbacher, Markus E., et al.. (2014). The LIM Domain Protein nTRIP6 Recruits the Mediator Complex to AP-1-Regulated Promoters. PLoS ONE. 9(5). e97549–e97549. 13 indexed citations
18.
Häuser, Roman, Markus Pech, Hiroshi Yamamoto, et al.. (2012). RsfA (YbeB) Proteins Are Conserved Ribosomal Silencing Factors. PLoS Genetics. 8(7). e1002815–e1002815. 77 indexed citations
19.
Kumar, Madhu, David C. Hancock, Míriam Molina‐Arcas, et al.. (2012). The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer. Cell. 149(3). 642–655. 215 indexed citations
20.
Schreck, Ilona, Marco Al‐Rawi, Markus E. Diefenbacher, et al.. (2011). c-Jun localizes to the nucleus independent of its phosphorylation by and interaction with JNK and vice versa promotes nuclear accumulation of JNK. Biochemical and Biophysical Research Communications. 407(4). 735–740. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiharu Uchida Breakdown of academic impact, for papers by Sohee Jun Breakdown of academic impact, for papers by Hui Dai Breakdown of academic impact, for papers by Yasuhiko Takahashi Breakdown of academic impact, for papers by Matthieu Lacroix Breakdown of academic impact, for papers by Kevin Myant Breakdown of academic impact, for papers by Larisa Litovchick Breakdown of academic impact, for papers by Bastiaan Evers Breakdown of academic impact, for papers by Yoko Itahana Breakdown of academic impact, for papers by Yuval Tabach
Rankless by CCL
2026